Metadata
- Name
- Autologous huMNC2-CAR44 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT04020575
- Description
- Phase I study of adoptive immunotherapy for advanced MUC1* positive breast cancer with
autologous T cells engineered to express a chimeric antigen receptor, huMNC2-CAR44 specific
for a cleaved form of MUC1 (MUC1*) - Data or Study Types
- clinical trial
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2019
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT04020575
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT04020575